Delivery Order SPE2DR25D2006-SPE2DR26F57GS
- Not listed
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $1,930.88 to AmerisourceBergen Drug Corp for the supply of Adderall tablets (30mg) on January 12, 2026, with an ultimate completion date of January 13, 2026. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement and...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $1,985.64 to AmerisourceBergen Drug Corp for the supply of Adderall tablets (30 mg) on January 2, 2026, with an ultimate completion date of January 5, 2026. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Adderall 20 mg tablets (100s) with a ceiling value of $9,254.51 under a firm fixed price contract type. The award was made on December 15, 2025, with an ultimate completion date of December 16, 2025, and represents a non-competitive procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs, particularly for...
- The Defense Logistics Agency awarded a delivery order valued at $7,596.12 to AmerisourceBergen Drug Corp on October 28, 2025, for the supply of Adderall 20 mg tablets (100-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of October 29, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $23,424.76 to AmerisourceBergen Drug Corp for Adderall 20 mg tablets (100 count) on September 24, 2025, with completion scheduled for September 25, 2025. This firm fixed-price delivery order represents a competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $6,128.30 to AmerisourceBergen Drug Corp for the supply of Adderall 10 mg tablets (100-count units) on November 24, 2025, with an ultimate completion date of November 25, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a delivery order valued at $23,489.50 to AmerisourceBergen Drug Corp for the supply of Adderall 20 mg tablets (100 count). This competitively awarded, firm fixed-price contract represents a non-set-aside procurement with an ultimate completion date of November 21, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a primary pharmaceutical distributor for federal medical procurement, with performance of this order...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $14,266.54 to AmerisourceBergen Drug Corp for the supply of Adderall 5 mg tablets (100-count units) under a firm fixed price contract. The order was competitively awarded without set-aside designation and carries an ultimate completion date of July 29, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor supporting federal medical procurement needs across...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $24,646.74 to AmerisourceBergen Drug Corp for the supply of Adderall 20 mg tablets (100-count units) under a firm fixed price contract. This non-set-aside delivery order, issued on December 8, 2025, with completion targeted for December 9, 2025, will be fulfilled from the vendor's Conshohocken, Pennsylvania location. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a...
- The Defense Logistics Agency awarded a delivery order valued at $1,939.56 to AmerisourceBergen Drug Corp for the supply of Adderall 15 mg tablets (100-count units) on September 18, 2025, with completion expected by September 19, 2025. This non-set-aside contract utilizes firm fixed pricing and represents a routine pharmaceutical procurement supporting federal medical supply needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor...
- SPE2DR25D2006Indefinite Delivery Contract
- SPE2DR25D2006-SPE2DR26F57GSDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $13,604.46 to AmerisourceBergen Drug Corp for the supply of Adderall 20 mg tablets (100-count units) on January 12, 2026, with an ultimate completion date of January 13, 2026. This competitively awarded, non-set-aside contract utilizes firm fixed-price pricing and is to be fulfilled at the contractor's Conshohocken, Pennsylvania location. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor serving federal healthcare needs across military and veteran systems. This delivery order operates under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 and extending through December 2026. This comprehensive global pharmaceutical support vehicle enables the contractor to supply a broad range of pharmaceutical products and medical supplies—including specialty medications, brand-name and generic drugs, vaccines, and medical devices—to support military healthcare programs worldwide and serve customers including the Defense Health Agency and U.S. Coast Guard. The contractor's significant contract portfolio demonstrates its established capability to meet federal procurement requirements across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.6k | 1/11/26 |